Vibration Training in Chronic Obstructive Pulmonary Disease (COPD)-Patients During a Three-week Rehabilitation

Sponsor

Schön Klinik Berchtesgadener Land (Other)

Overall Status

Completed

CT.gov ID

NCT01380652

Collaborator

(none)

Enrollment

Location

Arms

Duration (Months)

9.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of this study is to investigate the change of physical activity in COPD-patients performing a whole body vibration training additional to a standard three-week rehabilitation program in comparison to patients performing merely a standard rehabilitation program.

Condition or Disease	Intervention/Treatment	Phase
Chronic Obstructive Pulmonary Disease	Procedure: whole body vibration training	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

72 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

None (Open Label)

Primary Purpose:

Treatment

Official Title:

Effects of Whole Body Vibration Training on Physical Activity in Chronic Obstructive Pulmonary Disease (COPD) III/IV-Patients During a Three-week Rehabilitation

Study Start Date :

Sep 1, 2010

Actual Primary Completion Date :

Feb 1, 2011

Actual Study Completion Date :

May 1, 2011

Arms and Interventions

Arm	Intervention/Treatment
Experimental: rehabilitation with vibration training	Procedure: whole body vibration training pulmonary rehabilitation with strength and endurance training and additionally vibration training Other Names: whole body vibration Galileo
No Intervention: rehabilitation without vibration training

Arm

Intervention/Treatment

Experimental: rehabilitation with vibration training

Procedure: whole body vibration training

pulmonary rehabilitation with strength and endurance training and additionally vibration training

Other Names:

whole body vibration

Galileo

No Intervention: rehabilitation without vibration training

Outcome Measures

Primary Outcome Measures

Activity [day 2 and 17]
change in activity from baseline to day 17

Secondary Outcome Measures

Diffusion Capacity [day 1]
BODE-Score [day 1 and 19]
Changes in Bode-Score from baseline to day 19
lung function [day 1]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 75 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Chronic obstructive pulmonary disease III/IV

Exclusion Criteria:

Severe exacerbations in the last 4 weeks prior to begin of study (definition of exacerbation: symptoms on more than 3 days with a relevant change in drug therapy (cortisone, antibiotics))
Severe disease other than COPD, that could influence the results of the study
Abuse of alcohol or drugs
Simultaneously participation in another study
Tachypnea (>30/min)
Severe exacerbation during rehabilitation
Cardiac insufficiency (NYHA IV)
Myocardial infarction during the last 6 weeks
Mental-health problem
Pregnancy
Known HIV-infection
Slipped disk
Acute discopathy
Acute thrombosis
Implants in trained regions of the body (lower extremities)
Acute inflammation of the locomotor system, active arthrosis or rheumatoid arthritis
Acute tendinopathy in trained regions of the body
Acute hernia
Fresh fractures, wounds or scars in trained regions of the body
Gallstones or stones in the urinary tract collection system